|
1
|
Chen CJ, You SL, Lin LH, Hsu WL and Yang
YW: Cancer epidemiology and control in Taiwan: a brief review. Jpn
J Clin Oncol. 32(Suppl): S66–S81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB: Hepatocellular carcinoma: an
epidemiologic view. J Clin Gastroenterol. 35:S72–S78. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Keen N and Taylor S: Aurora-kinase
inhibitors as anticancer agents. Nat Rev Cancer. 4:927–936. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tuncel H, Shimamoto F, Kaneko Guangying Qi
H, et al: Nuclear Aurora B and cytoplasmic Survivin expression is
involved in lymph node metastasis of colorectal cancer. Oncol Lett.
3:1109–1114. 2012.PubMed/NCBI
|
|
5
|
Takeshita M, Koga T, Takayama K, et al:
Aurora-B overexpression is correlated with aneuploidy and poor
prognosis in non-small cell lung cancer. Lung Cancer. 80:85–90.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YJ, Chen CM, Twu NF, et al:
Overexpression of Aurora B is associated with poor prognosis in
epithelial ovarian cancer patients. Virchows Arch. 455:431–440.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qi G, Ogawa I, Kudo Y, et al: Aurora-B
expression and its correlation with cell proliferation and
metastasis in oral cancer. Virchows Arch. 450:297–302. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tovuu LO, Utsunomiya T, Imura S, et al:
The role of Aurora B expression in non-tumor liver tissues of
patients with hepatocellular carcinoma. Int J Clin Oncol. Jul
27–2013.(Epub ahead of print).
|
|
9
|
Sun DQ, Wang Y and Liu DG: Overexpression
of hnRNPC2 induces multinucleation by repression of Aurora B in
hepatocellular carcinoma cells. Oncol Lett. 5:1243–1249.
2013.PubMed/NCBI
|
|
10
|
Lin ZZ, Jeng YM, Hu FC, et al:
Significance of Aurora B overexpression in hepatocellular
carcinoma. Aurora B overexpression in HCC. BMC Cancer. 10:4612010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Benten D, Keller G, Quaas A, et al: Aurora
kinase inhibitor PHA-739358 suppresses growth of hepatocellular
carcinoma in vitro and in a xenograft mouse model. Neoplasia.
11:934–944. 2009.PubMed/NCBI
|
|
12
|
Tao T, Cheng C, Ji Y, et al: Numbl
inhibits glioma cell migration and invasion by suppressing
TRAF5-mediated NF-κB activation. Mol Biol Cell. 23:2635–2644.
2012.PubMed/NCBI
|
|
13
|
Jiang L, Wu J, Yang Y, et al: Bmi-1
promotes the aggressiveness of glioma via activating the
NF-κB/MMP-9 signaling pathway. BMC Cancer. 12:4062012.PubMed/NCBI
|
|
14
|
Long ZJ, Xu J, Yan M, et al: ZM 447439
inhibition of aurora kinase induces Hep2 cancer cell apoptosis in
three-dimensional culture. Cell Cycle. 7:1473–1479. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tatsuka M, Katayama H, Ota T, et al:
Multinuclearity and increased ploidy caused by overexpression of
the aurora- and Ipl1-like midbody-associated protein mitotic kinase
in human cancer cells. Cancer Res. 58:4811–4816. 1998.PubMed/NCBI
|
|
16
|
Kurai M, Shiozawa T, Shih HC, et al:
Expression of Aurora kinases A and B in normal, hyperplastic, and
malignant human endometrium: Aurora B as a predictor for poor
prognosis in endometrial carcinoma. Hum Pathol. 36:1281–1288. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sorrentino R, Libertini S, Pallante PL, et
al: Aurora B overexpression associates with the thyroid carcinoma
undifferentiated phenotype and is required for thyroid carcinoma
cell proliferation. J Clin Endocrinol Metab. 90:928–935. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spartà AM, Bressanin D, Chiarini F, et al:
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in
T-cell acute lymphoblastic leukemia. Cell Cycle. 13:May
29–2014.(Epub ahead of print).
|
|
19
|
Lu Y, Liu Y, Jiang J, et al: Knocking down
the expression of Aurora-A gene inhibits cell proliferation and
induces G2/M phase arrest in human small cell lung cancer cells.
Oncol Rep. 32:243–249. 2014.PubMed/NCBI
|
|
20
|
Zhu XP, Liu ZL, Peng AF, et al: Inhibition
of Aurora-B suppresses osteosarcoma cell migration and invasion.
Exp Ther Med. 7:560–564. 2014.PubMed/NCBI
|
|
21
|
Graham TR, Odero-Marah VA, Chung LW,
Agrawal KC, Davis R and Abdel-Mageed AB: PI3K/Akt-dependent
transcriptional regulation and activation of BMP-2-Smad signaling
by NF-kappaB in metastatic prostate cancer cells. Prostate.
69:168–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Andela VB, Gordon AH, Zotalis G, et al:
NF-κB: a pivotal transcription factor in prostate cancer metastasis
to bone. Clin Orthop Relat Res. (415 Suppl): S75–S85. 2003.
|
|
23
|
Felx M, Guyot MC, Isler M, et al:
Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving
the transcription factor NF-κB in human osteosarcoma. Clin Sci
(Lond). 110:645–654. 2006.PubMed/NCBI
|
